No OTC Cough, Cold Medicine for Toddlers: FDA

The U.S. Food and Drug Administration today issued a Public Health Advisory for parents and caregivers, recommending that over-the-counter (OTC) cough and cold products should not be used to treat infants and children less than 2 years of age because serious and potentially life-threatening side effects can occur from such use. OTC cough and cold products include decongestants, expectorants, antihistamines, and antitussives (cough suppressants) for the treatment of colds.

CDC said the wide variety of rare, serious adverse events reported with cough and cold products include death, convulsions, rapid heart rates, and decreased levels of consciousness.

"The FDA strongly recommends to parents and caregivers that OTC cough and cold medicines not be used for children younger than 2," said Charles Ganley, M.D., director of the FDA's Office of Nonprescription Products. "These medicines, which treat symptoms and not the underlying condition, have not been shown to be safe or effective in children under 2."

Today's statement is based on the FDA's review of data and discussion at a joint meeting of the Nonprescription Drugs and Pediatric Advisory Committees on Oct. 18 and 19, 2007. The announcement does not include the FDA's final recommendation about use of OTC cough and cold medicines in children ages 2 to 11 years as the agency's review of data is still continuing. Pending the results of that review, CDC recommends that parents and caregivers that choose to use OTC cough and cold medicines to children ages 2 to 11 years should:

  • Follow the dosing directions on the label of any OTC medication,
  • Understand that these drugs will NOT cure or shorten the duration of the common cold,
  • Check the "Drug Facts" label to learn what active ingredients are in the products because many OTC cough and cold products contain multiple active ingredients, and
  • Only use measuring spoons or cups that come with the medicine or those made specially for measuring drugs.

For more information and the full list of the FDA's recommendations, visit www.fda.gov/cder/drug/advisory/cough_cold_2008.htm.

Download Center

Featured Whitepapers

OH&S Digital Edition

  • OHS Magazine Digital Edition - July August 2021

    July/August 2021

    Featuring:

    • CONFINED SPACES
      Proper Use of Fall Protection PPE in a Confined Space
    • HAND PROTECTION
      Combining Innovations for the Perfect PPE
    • LOCKOUT/TAGOUT
      Tag in Supervisors on Lockout/Tagout
    • SAFETY LEADERSHIP
      Communication Insights for Supervision
    View This Issue